TargImmune Therapeutics - Ownership and Business Overview

Life ScienceCompany

TargImmune Therapeutics Ownership

Who owns TargImmune Therapeutics?

TargImmune Therapeutics is owned by iOncologi. It was acquired on March 14, 2025.

TargImmune Therapeutics Business Overview

Where is TargImmune Therapeutics headquartered?

TargImmune Therapeutics is headquartered in Basel, Switzerland.

What sector is TargImmune Therapeutics in?

TargImmune Therapeutics is a life science company.

When was TargImmune Therapeutics founded?

TargImmune Therapeutics was founded in 2016.

Life Science M&A Summary in 2025

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2025. The largest life science acquisition in 2025 was Intra-Cellular Therapies - which was acquired by Johnson & Johnson for $14.6B.

Join Mergr to view all 58 acquisitions of life science companies in 2025, including 3 acquisitions by private equity firms, and 55 by strategics.

TargImmune Therapeutics

TargImmune Therapeutics AG

Hochbergerstrasse 60C,
Basel, 4057
Switzerland,
+41 61 551 45 00
www.targimmune.com

TargImmune Therapeutics is a biotechnology company developing targeted immunotherapy solutions designed to enhance anti-tumor immune responses. TargImmune Therapeutics was founded in 2016 and is headquartered in Basel, Switzerland.


 Subscribe to unlock this and 212,526
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 206K M&A Transactions
  • 208K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for TargImmune Therapeutics

Life Science Companies , Switzerland Companies